Remedica: Dr Neoptolemou steps down as CEO
10:20 - 07 December 2023
Cyprus-based pharmaceutical company Remedica has announced the departure of its CEO, Dr Michael Neoptolemou.
The company said in its announcement that the doctor departs the company following an extremely successful 10 years.
Dr Neoptolemou joined Remedica in 2014 and had served as the company’s CEO since 2019, turning it from a family business to an international company with a presence in over 100 countries.
Under his leadership, Remedica significantly increased its series of products and made huge investments in its production capabilities. He safely led the company through two ownership changes – first from a family owned businesses to a South African Group and then bringing Remedica back under private ownership with headquarters in Cyprus, supported by international investmors with a long-term commitment to growth, innovation and investments.
Today, Remedica is one of Cyprus’ biggest exporters.
The company said the CEO change is part of Remedica’s move to the next stage of its growth strategy, for which it has already set the foundations. Over the past two years, Remedica launched its biggest ever investment programme, investing in the development of new products and expanded production capabilities.
“The Board of Directors and executive team will ensure business continuity and remain dedicated to growth and innovation,” Remedica concluded in its announcement.